GOLDMAN SACHS GROUP INC - WUXI PHARMATECH CAYMAN INC ownership

WUXI PHARMATECH CAYMAN INC's ticker is WX and the CUSIP is 929352102. A total of 152 filers reported holding WUXI PHARMATECH CAYMAN INC in Q3 2015. The put-call ratio across all filers is 2.14 and the average weighting 0.7%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of WUXI PHARMATECH CAYMAN INC
ValueSharesWeighting
Q3 2015$3,974,000
+257.1%
91,980
+249.0%
0.00%
Q2 2015$1,113,000
-51.3%
26,357
-55.2%
0.00%
-100.0%
Q1 2015$2,284,000
+10.4%
58,886
-4.2%
0.00%0.0%
Q4 2014$2,069,000
+27.6%
61,449
+32.7%
0.00%0.0%
Q3 2014$1,622,000
+431.8%
46,319
+399.3%
0.00%
Q2 2014$305,000
+25.0%
9,276
+40.4%
0.00%
Q1 2014$244,000
-7.9%
6,609
-31.6%
0.00%
Q3 2013$265,000
+74.3%
9,665
-5.1%
0.00%
Q3 2012$152,000
-71.9%
10,180
-72.9%
0.00%
Q1 2012$541,00037,5980.00%
Other shareholders
WUXI PHARMATECH CAYMAN INC shareholders Q3 2015
NameSharesValueWeighting ↓
Coupland Cardiff Asset Management LLP 241,186$9,353,00020.89%
Sensato Investors LLC 672,513$26,080,0005.62%
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC 2,781,889$107,882,0003.77%
Sloane Robinson LLP 57,500$2,230,0003.35%
Grandeur Peak Global Advisors, LLC 344,518$13,360,0002.83%
THOMAS WHITE INTERNATIONAL LTD 474,694$18,409,0002.58%
Granite Point Capital Management, L.P. 180,000$6,980,0002.56%
COMGEST GLOBAL INVESTORS S.A.S. 2,058,180$79,816,0002.49%
PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC 234,071$9,077,0002.47%
DECADE CAPITAL MANAGEMENT LLC 389,735$15,114,0001.87%
View complete list of WUXI PHARMATECH CAYMAN INC shareholders